Giovanni Di Guardo Selected Research

Morbillivirus Infections

1/2021

Retrospective immunohistochemical investigation on dolphin morbillivirus infection by comparing the performance of heterologous monoclonal and polyclonal antibodies - Short communication.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanni Di Guardo Research Topics

Disease

8	Infections 02/2022 - 06/2008
7	Scrapie 01/2018 - 09/2003
2	Skin Diseases (Skin Disease) 01/2018 - 09/2009
2	Inflammation (Inflammations) 01/2013 - 04/2010
1	Demyelinating Diseases (Demyelinating Disease) 12/2022
1	Noise-Induced Hearing Loss (Acoustic Trauma) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Pathologic Processes 01/2022
1	Morbillivirus Infections 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2020
1	Hypertension (High Blood Pressure) 08/2020
1	Disease Progression 08/2020
1	COVID-19 08/2020
1	Pathologic Constriction (Stenosis) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 02/2013
1	Neoplasms (Cancer) 12/2012
1	Eosinophilia 11/2011
1	Toxoplasmosis 09/2009
1	Wounds and Injuries (Trauma) 09/2009
1	Communicable Diseases (Infectious Diseases) 09/2009
1	Lobomycosis 09/2009
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 07/2008

Drug/Important Bio-Agent (IBA)

6	PrionsIBA 01/2014 - 06/2008
3	Prion ProteinsIBA 01/2018 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2022
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 09/2003
2	AntibodiesIBA 01/2022 - 01/2021
2	AntigensIBA 12/2019 - 02/2013
2	Environmental Pollutants (Pollutants, Environmental)IBA 01/2018 - 03/2012
1	Glycoproteins (Glycoprotein)IBA 02/2022
1	neurofilament protein HIBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	PlasticsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2020
1	Antihypertensive Agents (Antihypertensives)IBA 08/2020
1	Angiotensin Receptor AntagonistsIBA 08/2020
1	Pharmaceutical PreparationsIBA 08/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2019
1	Phenobarbital (Luminal)FDA Link 01/2018
1	Polychlorinated Biphenyls (PCBs)IBA 01/2018
1	pleiotrophin (HARP)IBA 12/2014
1	PrPSc ProteinsIBA 01/2013
1	Messenger RNA (mRNA)IBA 01/2013
1	Lymphotoxin-alpha (Lymphotoxin)IBA 01/2013
1	Oncogene Proteins (Oncogene Protein)IBA 12/2012
1	DDTIBA 03/2012
1	domoic acidIBA 11/2011
1	Biological ProductsIBA 09/2009
1	CalbindinsIBA 10/2007
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 10/2007
1	Codon (Codons)IBA 01/2006
1	Lysine (L-Lysine)FDA Link 01/2006
1	Monoclonal AntibodiesIBA 09/2003

Therapy/Procedure

2	Tattooing 01/2018 - 09/2009